The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa | SpringerLink
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology
The Combination of Nuclear Factor Kappa B, Cyclo-oxygenase- 2 and Vascular Endothelial Growth Factor Expression Predicts Poor Pr
Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence. - Abstract - Europe PMC
The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease | SpringerLink
Cancers | Free Full-Text | NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB | HTML
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Signaling mechanisms of ROS-mediated nuclear factor kappa-B (NF-κB)... | Download Scientific Diagram
Nuclear Factor Kappa-B: Bridging Inflammation and Cancer | 2 | Gene Re
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
Cancers | Free Full-Text | Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer—from Tumor Development to Therapeutic Implications | HTML
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology
Nuclear Factor Kappa B Pathway and human cancer therapeutics
Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism – ScienceOpen
PDF) Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism | Narayan Mandal - Academia.edu
Genistein as a regulator of signaling pathways and microRNAs in different types of cancers | Cancer Cell International | Full Text
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression
الإشارة برغي المستأجر nuclear factor kappa b cancer - cours-de-cuisine-en-francais-a-bali-ubud.net
Is NF-κB a good target for cancer therapy? Hopes and pitfalls | Nature Reviews Drug Discovery
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports
NF-κB in the New Era of Cancer Therapy: Trends in Cancer
